Last reviewed · How we verify

NCT04616898

Analysis of the Performance of 1060 nm Diode and Radio Frequency Prior to Abdominoplasty

Completed NA Last updated 21 August 2024
What this trial tests

NA trial testing Venus Bliss in Adipose Tissue Atrophy in 12 participants. Completed in 27 November 2023.

Timeline
1 July 2020
Primary endpoint
27 November 2023
27 November 2023

Quick facts

Lead sponsorVenus Concept
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment12
Start date1 July 2020
Primary completion27 November 2023
Estimated completion27 November 2023
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Venus Concept

Who can join

Adults 21 to 60, any sex, with Adipose Tissue Atrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the safety and efficacy of treatment with 1060nm diode laser and radio frequency to be analyzed through histological and molecular analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Venus Bliss

Trials testing the same drug.

Other Venus Concept trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04616898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing